Home › Companies › CARDLYTICS INC. › 2023-2024

CARDLYTICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and CARDLYTICS INC.’s Form 8-K, filed 2024-05-23 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 5Reported items
  • 155Asset managers
  • 735Fund votes
  • 2024-05-23Meeting date

Proxy season: 2023-2024 2024-2025

Explore CARDLYTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by CARDLYTICS INC.

These tallies are CARDLYTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-23 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CARDLYTICS INC. — official shareholder meeting results, meeting held 2024-05-23
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Andre Fernandez 24,833,464---- 531,612-- Majority: yes
Elect Director: Liane Hornsey 24,855,936---- 509,140-- Majority: yes
Elect Director: Ratification of Selection of Deloitte & Touche LLP 35,218,022155,179337,079 ---- Majority: yes
Elect Director: Approval of Compensation of the Company's Named Executive Officers 15,925,2199,043,339396,518 ---- Majority: yes

Source: CARDLYTICS INC., Form 8-K, filed with the SEC on 2024-05-23 — read the filing on EDGAR.

How asset managers voted at the CARDLYTICS INC. 2023-2024 meeting

Each item below shows how the 155 asset managers that disclosed a CARDLYTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CARDLYTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Advisory vote to approve compensation of named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

64% Majority: yes · of votes cast

FOR 64%AGAINST 36%
FOR: 15,925,219AGAINST: 9,043,339

CARDLYTICS INC.’s own tally for this item (“Elect Director: Approval of Compensation of the Company's Named Executive Officers”): 15,925,219 for, 9,043,339 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,783,041 outstanding shares: 33% for, 19% against (51.2% of the company cast a for/against vote).

The 150 asset managers below cast 60% of the shares they voted on this item FOR (14,302,661 for, 9,351,093 against).

FOR 60%AGAINST 39%
FOR: 14,302,661 (59.9%)AGAINST: 9,351,093 (39.2%)ABSTAIN: 228,333 (1.0%)NOT VOTED: 0 (0.0%)
Largest asset managers voting on “Advisory vote to approve compensation of named executive officers.” at CARDLYTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
CAS Investment Partners, LLC6,373,5760 00For
Morgan Stanley2,447,4841,317 00For
Vanguard2,209,9770 00For
BlackRock10,2672,015,345 00Against
683 Capital Management, LLC01,844,354 00Against
KPS Global Asset Management UK Ltd1,218,8300 00For
BAILLIE GIFFORD & CO LTD0658,448 00Against
Charles Schwab0634,162 00Against
General Equity Holdings LP624,0580 00For
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP549,7940 00For
State Street399,8741,113 00For
DE Shaw0385,383 00Against
UBS0362,292 00Against
GEODE CAPITAL MANAGEMENT, LLC0339,233 00Against
MARSHALL WACE, LLP0332,316 00Against
Dimensional0329,837 00Against
Fidelity0286,213 00Against
Equitable143,800102,099 00For
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.00 215,9250Abstain
Northern Trust188,5120 00For
JACOBS LEVY EQUITY MANAGEMENT, INC0173,162 00Against
Goldman Sachs0124,048 00Against
SEI0115,427 00Against
BESSEMER INVESTMENT MANAGEMENT LLC0112,952 00Against
OLD WESTBURY FUNDS INC0112,952 00Against

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

2. THE RATIFICATION OF THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 35,218,022AGAINST: 155,179

CARDLYTICS INC.’s own tally for this item (“Elect Director: Ratification of Selection of Deloitte & Touche LLP”): 35,218,022 for, 155,179 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,783,041 outstanding shares: 72% for, 0.4% against (73% of the company cast a for/against vote).

The 49 asset managers below cast 99.9% of the shares they voted on this item FOR (6,032,335 for, 105 against).

FOR 99.9%
FOR: 6,032,335 (100.0%)AGAINST: 105 (0.0%)
Largest asset managers voting on “THE RATIFICATION OF THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF DELOITTE & TOUCHE LLP AS” at CARDLYTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,170,7680 00For
BlackRock1,357,7490 00For
Morgan Stanley711,5130 00For
Charles Schwab317,0810 00For
Fidelity285,0240 00For
Dimensional284,7430 00For
Equitable245,8990 00For
OLD WESTBURY FUNDS INC112,9520 00For
MFS77,8440 00For
QUANTITATIVE MASTER SERIES LLC60,0680 00For
SEI57,3200 00For
Goldman Sachs51,5960 00For
Nationwide37,3890 00For
Lincoln Financial33,6230 00For
HC CAPITAL TRUST23,8680 00For
Capitol Series Trust23,7000 00For
Columbia Threadneedle21,3770 00For
Global X18,7710 00For
Pacific Life16,0700 00For
Northern Trust15,8590 00For
Bridge Builder Trust14,2670 00For
AQR12,1880 00For
FORUM FUNDS II8,7000 00For
John Hancock7,2340 00For
Voya6,2040 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

3. Election of Directors: Andre Fernandez

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 24,833,464WITHHELD: 531,612

CARDLYTICS INC.’s own tally for this item (“Elect Director: Andre Fernandez”): 24,833,464 for, 531,612 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,783,041 outstanding shares: 50.9% for, 1% withheld (52.0% of the company cast a for/withheld vote).

The 47 asset managers below cast 100% of the shares they voted on this item FOR (5,947,386 for, 0 against).

FOR 99%
FOR: 5,947,386 (98.7%)ABSTAIN: 77,844 (1.3%)
Largest asset managers voting on “Election of Directors: Andre Fernandez” at CARDLYTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,170,7680 00For
BlackRock1,357,7490 00For
Morgan Stanley711,5130 00For
Charles Schwab317,0810 00For
Fidelity285,0240 00For
Dimensional284,7430 00For
Equitable245,8990 00For
OLD WESTBURY FUNDS INC112,9520 00For
MFS00 77,8440Abstain
QUANTITATIVE MASTER SERIES LLC60,0680 00For
SEI57,3200 00For
Goldman Sachs51,5960 00For
Nationwide37,3890 00For
Lincoln Financial33,6230 00For
HC CAPITAL TRUST23,8680 00For
Capitol Series Trust23,7000 00For
Columbia Threadneedle21,3770 00For
Global X18,7710 00For
Pacific Life16,0700 00For
Northern Trust15,8590 00For
Bridge Builder Trust14,2670 00For
AQR12,1880 00For
FORUM FUNDS II8,7000 00For
John Hancock7,2340 00For
Voya6,2040 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

4. Election of Directors: Liane Hornsey

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 24,855,936WITHHELD: 509,140

CARDLYTICS INC.’s own tally for this item (“Elect Director: Liane Hornsey”): 24,855,936 for, 509,140 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,783,041 outstanding shares: 51.0% for, 1% withheld (52.0% of the company cast a for/withheld vote).

The 47 asset managers below cast 100% of the shares they voted on this item FOR (6,019,829 for, 0 against).

FOR 99.9%
FOR: 6,019,829 (99.9%)ABSTAIN: 5,401 (0.1%)
Largest asset managers voting on “Election of Directors: Liane Hornsey” at CARDLYTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,170,7680 00For
BlackRock1,357,7490 00For
Morgan Stanley711,5130 00For
Charles Schwab317,0810 00For
Fidelity285,0240 00For
Dimensional284,7430 00For
Equitable245,8990 00For
OLD WESTBURY FUNDS INC112,9520 00For
MFS77,8440 00For
QUANTITATIVE MASTER SERIES LLC60,0680 00For
SEI57,3200 00For
Goldman Sachs51,5960 00For
Nationwide37,3890 00For
Lincoln Financial33,6230 00For
HC CAPITAL TRUST23,8680 00For
Capitol Series Trust23,7000 00For
Columbia Threadneedle21,3770 00For
Global X18,7710 00For
Pacific Life16,0700 00For
Northern Trust15,8590 00For
Bridge Builder Trust14,2670 00For
AQR12,1880 00For
FORUM FUNDS II8,7000 00For
John Hancock7,2340 00For
Voya6,2040 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

5. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

64% Majority: yes · of votes cast

FOR 64%AGAINST 36%
FOR: 15,925,219AGAINST: 9,043,339

CARDLYTICS INC.’s own tally for this item (“Elect Director: Approval of Compensation of the Company's Named Executive Officers”): 15,925,219 for, 9,043,339 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,783,041 outstanding shares: 33% for, 19% against (51.2% of the company cast a for/against vote).

The 3 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 267,023 against).

AGAINST 100%
AGAINST: 267,023 (100.0%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at CARDLYTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Tenzing Global Management, LLC0226,386 00Against
Capitol Series Trust023,700 00Against
ALGERT GLOBAL LLC016,937 00Against

Largest CARDLYTICS INC. shareholders voting in 2023-2024

Ranked by the number of CARDLYTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 48,783,041 shares outstanding at the time of that meeting.

Top CARDLYTICS INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1CAS Investment Partners, LLC 13.07%
2Morgan Stanley 5.02%
3Vanguard 4.53%
4BlackRock 4.15%
5683 Capital Management, LLC 3.78%
6KPS Global Asset Management UK Ltd 2.50%
7BAILLIE GIFFORD & CO LTD 1.35%
8Charles Schwab 1.30%
9General Equity Holdings LP 1.28%
10DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 1.13%

Reported CARDLYTICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

CARDLYTICS INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
Entities affiliated with CAS Investment Partners, LLC 13.07% DEF14A
Entities affiliated with BlackRock, Inc. . 5.97% DEF14A
Vanguard Group 4.92% 13F
Alex Mishurov 2.78% DEF14A
BlackRock 1.99% 13F
Geode Capital 1.74% 13F
Dimensional Fund Advisors 1.60% 13F
Citadel Advisors 1.59% 13F
State Street 1.54% 13F
Invesco 1.42% 13F

Percentages above are of 48,783,041 shares outstanding, as reported by CARDLYTICS INC. on its Form 10-Q dated 2024-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CARDLYTICS INC.’s 10-Q dated 2024-04-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At CARDLYTICS INC.'s shareholder meeting held 2024-05-23, in the 2023-2024 proxy season, 155 asset managers reported how they voted in their SEC Form N-PX filings, covering 735 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote to approve compensation of named executive officers. — FOR was 64% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CARDLYTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-23.

CARDLYTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.